These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 8559262)
1. [Encapsulated dopamine-secreting cells transplanted into the brain: a possible therapy for Parkinson's disease]. Miyoshi Y; Date I; Ono T; Imaoka T; Asari S; Ohmoto T; Iwata H No Shinkei Geka; 1996 Jan; 24(1):35-9. PubMed ID: 8559262 [TBL] [Abstract][Full Text] [Related]
2. Histological analysis of microencapsulated dopamine-secreting cells in agarose/poly(styrene sulfonic acid) mixed gel xenotransplanted into the brain. Miyoshi Y; Date I; Ohmoto T; Iwata H Exp Neurol; 1996 Mar; 138(1):169-75. PubMed ID: 8593892 [TBL] [Abstract][Full Text] [Related]
3. Preliminary report of polymer-encapsulated dopamine-secreting cell grafting into the brain. Date I; Miyoshi Y; Ono T; Imaoka T; Furuta T; Asari S; Ohmoto T; Iwata H Cell Transplant; 1996; 5(5 Suppl 1):S17-9. PubMed ID: 8889222 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of reaction of primate brain to grafted PC12 cells. Yoshida H; Date I; Shingo T; Fujiwara K; Miyoshi Y; Furuta T; Ohmoto T Cell Transplant; 1999; 8(4):427-30. PubMed ID: 10478724 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of intracerebral grafting of dopamine-secreting PC12 cells into allogeneic and xenogeneic brain. Ono T; Date I; Imaoka T; Shingo T; Furuta T; Asari S; Ohmoto T Cell Transplant; 1997; 6(5):511-3. PubMed ID: 9331503 [TBL] [Abstract][Full Text] [Related]
10. Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: long-term primate study. Date I; Shingo T; Yoshida H; Fujiwara K; Kobayashi K; Ohmoto T Cell Transplant; 2000; 9(5):705-9. PubMed ID: 11144970 [TBL] [Abstract][Full Text] [Related]
11. Formulation and Characterization of Microcapsules Encapsulating PC12 Cells as a Prospective Treatment Approach for Parkinson's Disease. Joshi DJ; Chitre NM; Bansal A; Murnane KS; D'Souza MJ AAPS PharmSciTech; 2021 May; 22(4):149. PubMed ID: 33961149 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study. Yoshida H; Date I; Shingo T; Fujiwara K; Kobayashi K; Miyoshi Y; Ohmoto T J Neurosurg; 2003 Apr; 98(4):874-81. PubMed ID: 12691415 [TBL] [Abstract][Full Text] [Related]
15. Growth of tumour cell lines in polymer capsules: ultrastructure of encapsulated PC12 cells. Jaeger CB; Aebischer P; Tresco PA; Winn SR; Greene LA J Neurocytol; 1992 Jul; 21(7):469-80. PubMed ID: 1500946 [TBL] [Abstract][Full Text] [Related]
16. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease. Quinn M; Mukhida K; Sadi D; Hong M; Mendez I Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176 [TBL] [Abstract][Full Text] [Related]
17. Neurorescue effects of VEGF on a rat model of Parkinson's disease. Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899 [TBL] [Abstract][Full Text] [Related]